U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07496736) titled 'Post-exposure Influenza Prophylaxis' on March 22.
Brief Summary: The purpose of this study is to compare the efficacy of 5-day versus 10- day oseltamivir prophylactic treatment in patients who had been exposed to influenza.
Study Start Date: Dec. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Influenza
Intervention:
DRUG: Oseltamivir (Tamiflu)
oseltamivir 5 days
DRUG: Oseltamivir (Tamiflu)
oseltamivir 10 days
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: University Medical Centre Ljubljana
Information provided by (Responsible Party): Dasa Stupica, University Medical Centre Ljubljana
Disclaimer: Curated by HT Syndi...